Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Non-Current Assets (2016 - 2025)

Altimmune (ALT) has disclosed Non-Current Assets for 16 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 15.35% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, up 4.72% year-over-year, with the annual reading at $1.7 million for FY2025, 15.35% down from the prior year.
  • Non-Current Assets for Q4 2025 was $1.7 million at Altimmune, down from $1.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $19.1 million in Q1 2021, with the low at $843000.0 in Q1 2024.
  • Average Non-Current Assets over 5 years is $9.3 million, with a median of $13.7 million recorded in 2023.
  • The sharpest move saw Non-Current Assets tumbled 93.97% in 2024, then soared 137.37% in 2025.
  • Over 5 years, Non-Current Assets stood at $14.7 million in 2021, then dropped by 4.23% to $14.1 million in 2022, then crashed by 92.82% to $1.0 million in 2023, then skyrocketed by 102.37% to $2.1 million in 2024, then dropped by 15.35% to $1.7 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $1.7 million, $1.8 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.